Go to deals
Healthcare

Chirana T. Injecta, a.s. has acquired Vitrex Medical A/S

Chirana T. Injecta, a.s. has announced the acquisition of Vitrex Medical A/S, the Danish disposable medical and laboratory devices manufacturing company developing, producing and selling disposable articles, primarily for blood sample taking and analysis. Financial details have not been disclosed.

Chirana T. Injecta, a.s. is a manufacturer of disposable medical devices (lancets, syringes, needles, cannulas).

Oaklins' team in the Czech Republic advised the buyer in this transaction.

Parties

Talk to the deal team

 Vladimír  Jaros

Vladimír Jaros

Principal
Prague, Czech Republic
Oaklins WOOD & Co.
 Michal  Staron

Michal Staron

Managing Director
Bratislava, Slovakia
Oaklins WOOD & Co.

Related deals

move UP has been acquired by Acture B.V.
Private Equity | Business Support Services | Healthcare

move UP has been acquired by Acture B.V.

move UP Gesellschaft für Gesundheitsmanagement mbH, an innovative provider of holistic corporate health management solutions, has been acquired by Acture B.V., a leader in welfare management. This acquisition represents a major step in Acture’s plans to expand into the German corporate health management sector.

Learn more
Sopharma Group has acquired two pharmaceutical products in Poland
Healthcare

Sopharma Group has acquired two pharmaceutical products in Poland

Sopharma Group has acquired Coffepirine and Kopiryna, two highly recognized medicines to treat headache. The acquisition will further expand the market presence of Sopharma Group in the Polish market and support the promising potential of the two pharmaceutical drugs.

Learn more
Alcidion has raised capital
Healthcare

Alcidion has raised capital

Alcidion Group Ltd. (ASX:ALC) has raised capital via an institutional placement. The placement was well supported by existing shareholders whilst also welcoming several new institutional shareholders to the register. Proceeds from the raise will provide Alcidion with maximum flexibility and ensure a strong balance sheet to execute on its market opportunities and enable the firm to continue to drive revenue growth.

Learn more